Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study

Documenti analoghi

• Long‐term delirium and survival outcomes in patients treated with GLP ‐1 receptor agonists versus metformin in type 2 diabetes: A population‐based cohort study
  di: Mingyang Sun, et al.
  Pubblicazione: (2025)
• Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
  di: Mingyang Sun, et al.
  Pubblicazione: (2024)
• Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
  di: Jiaqiang Zhang, et al.
  Pubblicazione: (2025)
• Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
  di: Jingchuan Guo, et al.
  Pubblicazione: (2024)
• Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study
  di: Maria J. Alfonso Arvez, et al.
  Pubblicazione: (2025)